About 100 reports

Biotech-based economy/ industry is also an integral part of Prime Minister Abe' s growth strategy in the " Growth Strategy 2017 - Society ##. ##. "

  • Hospital
  • Japan
  • Market Size
  • Roche Group
  • Terumo Corporation

The favorable side effect of the brand is one of the major reasons for growth of the brand.

  • Hospital
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Lilly Endowment Inc.
  • Pfizer Inc.

China will continue to advocate a one child family policy and population growth will decline moderately in next few years.

  • Hospital
  • China
  • Demand
  • Market Size
  • Supply

Hormones are carried in our bloodstream and act as messengers between one part of our body and another.

  • Hospital
  • China
  • Demand
  • Supply
  • Novartis AG

DOCTORS MAY ALSO REMOVE HORMONE GLANDS TO KILL CANCER CELLS OR PREVENT FURTHER CANCEROUS GROWTH.

  • Hospital
  • China
  • Market Size
  • Supply
  • Shenzhen Kangtai Biological Products Co.

OPKO BIOLOGICS, MOD-## (LONG-LASTING HUMAN GROWTH HORMONE (HGH)) STUDY IN GROWTH HORMONE DEFICIENT ADULTS (GHDA), NCT##.

  • Hospital
  • United States
  • Novo Nordisk Group
  • Pfizer Inc.
  • Versartis, Inc.

China will continue to advocate a one child family policy and population growth will decline moderately in next few years.

  • Hospital
  • China
  • Demand
  • Abbott Laboratories, Inc.
  • Shanghai Jahwa United Co., Ltd.

It mainly produces corticoid and sex hormones (progesterone, estrogen and androgen).

  • Hospital
  • China
  • Demand
  • Trade
  • AstraZeneca PLC

It is also common to combine radiation therapy with surgery, chemotherapy, hormone therapy, immunotherapy or some mixture of the four.

  • Hospital
  • China
  • Demand
  • Market Size
  • Shenzhen International Holdings Limited

THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) CAUSES AIDS.

  • Hospital
  • China
  • Demand
  • Market Size
  • Supply

TABLE ##: APPETITIVE INHIBITORS OUTPUT AND DEMAND (MILLION US DOLLARS) Chapter IV WEIGHT LOSS AND DIET PRODUCTS OUTPUTS AND FORECASTS Metabolizability Irritants The familiar Metabolizability Irritants have Ephedrine, Caffeine, Hypothyroid Hormone, Growth Hormone, and Metfo

  • Hospital
  • China
  • Demand
  • Market Size
  • Supply

COMPUTER MONITORS PUTS A SPECIAL DEMAND ON HUMAN VISION.

  • Hospital
  • China
  • Demand
  • Market Size
  • Supply

ACCORDING TO CHINA' S HUMAN RESOURCES MARKET INFORMATION, TECHNICIANS AND ENGINEERS' JOB VACANCIES AND JOB SEEKERS ARE MUCH HIGHER.

  • Dental Equipment
  • Hospital
  • China
  • Supply
  • Beijing Wandong Medical Equipment Co., Ltd.

THE COMPANY CLAIMS THAT ITS PROPRIETARY PRODUCTS HAVE THE POTENTIAL TO PROVIDE A NATURAL, SAFE AND EFFECTIVE ENVIRONMENT FOR TREATING NUMEROUS CHRONIC DISEASES, SUCH AS HAEMOPHILIA, HUMAN GROWTH HORMONE DEFICIENCY, PARATHYROID HORMONE DEFICIENCY, AND PARKINSON

  • Hospital
  • United States
  • Erytech Pharma SA
  • Neurotech Pharmaceuticals, Inc.
  • ViaCyte, Inc.

Healthcare Epidemiology Forecast to 2026 EPICAST REPORT: GROWTH HORMONE DEFICIENCY Report Code: Published: GDHCER##-## June 2017 ## ## ## Executive Summary GROWTH HORMONE DEFICIENCY (GHD) IS CHARACTERIZED BY LOW SECRETION OF GROWTH

  • Hospital
  • Japan
  • United States
  • World
  • Forecast

In February 2015, a collaboration agreement was finalized with OPKO Health to develop Significant Agreements and Collaboration Pfizer' s tanezumab. and commercialize OPKO' s long-acting human growth hormone.

  • Hospital
  • Latin America
  • Mexico
  • North America
  • Market Size

It offers products, such as Corticosterone ##H (Rat), rLH RIA kit, Rat Growth Hormone [##I] RIA, and others.

  • Hospital
  • Europe
  • Beckman Coulter, Inc.
  • DiaSorin S.p.A.
  • DIAsource ImmunoAssays SA
  • REIMBURSEMENT

A priori Human Growth Hormone Program drugs (somatropin) dispensed to out- and day patients, and patients on discharge from hospital.

  • Health Services
  • Hospital
  • Pharmaceutical
  • Australia
  • ENDOCRINOLOGY TESTS - PIPELINE PRODUCTS BY STAGE OF DEVELOPMENT

Human Resources Div.

  • Clinical Trial
  • Hospital
  • Immunodiagnostics
  • Medical Biotechnology
  • Siemens Healthcare GmbH

TABLE ## Growth hormone therapy involves the use of growth hormones as medication for normal growth and development.

  • Hospital
  • North America
  • United States
  • World
  • Sanofi S.A.

The increase in research and development expenses was primarily due to an increase in research and development expenses related to hGH-CTP, a long acting human growth hormone which was out-licensed to Pfizer in 2015, and to the acquisition of Transition Therapeutics in Aug

  • Hospital
  • Europe
  • United States
  • World
  • GW Pharmaceuticals plc

The Diabetes and Obesity Care segment offers new-generation insulins, modern insulins (insulin analogs), human insulins, glucagon-like-peptide ##, oral antibiotic products, and needles, among others.

  • Hospital
  • North America
  • United States
  • World
  • Market Size

FOR HUMAN GROWTH HORMONE, BIOSIMILAR PENETRATION IN 2013 RANGED FROM ##% MARKET SHARE IN CROATIA, PORTUGAL, IRELAND, AND SLOVAKIA, TO ##% IN POLAND.

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Europe
  • EFPIA company

It is used for hormone-based therapies using insulin, human growth hormone (hGh), follicle-stimulating hormone (FSH), parathyroid hormone (PTH), and glucagon-like peptide-## (GLP-##). ##. ##. ##. ##. ## COMMERCIALLY AVAILA

  • Hospital
  • Topical Delivery
  • North America
  • United States
  • Pfizer Inc.

Its ZOMACTON product is a synthetic human growth hormone used to treat growth hormone deficiency in children.

  • Hospital
  • United States
  • World
  • Company
  • Ferring International Center S.A.

NOVO NORDISK ALSO OFFERS BIOPHARMACEUTICALS FOR TREATING HAEMOSTASIS, HUMAN GROWTH HORMONE PRODUCTS AND HORMONE REPLACEMENT THERAPY.

  • Clinical Trial
  • Hospital
  • Injectable Delivery
  • Therapy
  • Merck & Co., Inc.

Novo Nordisk also offers biopharmaceuticals for treating haemostasis, human growth hormone products, hormone replacement therapy and other serious chronic diseases.

  • Healthcare
  • Hospital
  • United States
  • M&A
  • Humana Inc.
  • Clinical Trial profile. 57 Trial Title

Biogen and Ionis conducted an innovative clinical development program, the largest of its kind in SMA, that moved SPINRAZA from its first dose in humans in 2011 to its first regulatory approval in five years.

  • Drug Development
  • Hospital
  • Pharmaceutical
  • World
  • Product Initiative

RHGH ACTS BY TARGETING GROWTH HORMONE RECEPTOR.

  • Hospital
  • Renal Disease
  • United States
  • Product Initiative
  • Angion Biomedica Corp.

Novo Nordisk also offers biopharmaceuticals for treating haemostasis, human growth hormone products, hormone replacement therapy and other serious chronic diseases.

  • Hospital
  • Pharmaceutical
  • Therapy
  • United States
  • Aduro BioTech, Inc.